UBS (Lux) Digital Health Equity Fund (CHF hedged) QL-acc
WKN A2QFTV | ISIN LU2242307960 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU2346866317 | Candriam Equities L Oncology, N - Capitalisation | +39,53 % | +16,40 % | 2,25 |
|
| 2 | LU2387456671 | Franklin Genomic Advancements Fund - I (acc) EUR | +51,11 % | +21,96 % | 2,21 |
|
| 3 | IE000G3N3NE7 | Janus Henderson Global Life Sciences Fund G2 EUR | +36,70 % | +15,52 % | 2,20 |
|
| 4 | IE00BRJG6X20 | Janus Henderson Global Life Sciences Fund I2 EUR | +35,57 % | +15,48 % | 2,13 |
|
| 5 | LU2387457729 | Franklin Genomic Advancements Fund - N (acc) EUR | +48,54 % | +22,00 % | 2,09 |
|
| 338 | LU0580275534 | Bellevue Funds (Lux) - Bellevue Medtech & Services HB EUR - Accumulating | -14,58 % | +16,47 % | -1,04 |
|
| 339 | LU0969575645 | Variopartner SICAV - MIV Global Medtech Fund I3 USD | -16,12 % | +17,31 % | -1,08 |
|
| 340 | LU1050446076 | Variopartner SICAV - MIV Global Medtech Fund N3 USD | -16,29 % | +17,31 % | -1,09 |
|
| 341 | LU0969575561 | Variopartner SICAV - MIV Global Medtech Fund P3 USD | -16,62 % | +17,31 % | -1,11 |
|
| 342 | LU0580237955 | Bellevue Funds (Lux) - Bellevue Medtech & Services HB CHF - Accumulating | -16,09 % | +16,47 % | -1,14 |
|